BOSTON SCIENTIFIC CORPORATION Disposal Group, Including Discontinued Operation, Revenue
BOSTON SCIENTIFIC CORPORATION (BSX) reported Disposal Group, Including Discontinued Operation, Revenue of $1.00 million for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-08-06.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2014-11-05
- BOSTON SCIENTIFIC CORPORATION disposal group, including discontinued operation, revenue for the quarter ending 2014-06-30 was $1.00M, a 94.74% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION disposal group, including discontinued operation, revenue for the quarter ending 2014-03-31 was $2.00M, a 94.44% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION disposal group, including discontinued operation, revenue for the quarter ending 2013-12-31 was $2.00M, a 93.55% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION disposal group, including discontinued operation, revenue for the quarter ending 2013-09-30 was $2.00M, a 93.75% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION disposal group, including discontinued operation, revenue for fiscal 2013 was $58.00M, a 52.46% decline from fiscal 2012.
- BOSTON SCIENTIFIC CORPORATION disposal group, including discontinued operation, revenue for fiscal 2012 was $122.00M, a 13.48% decline from fiscal 2011.
- BOSTON SCIENTIFIC CORPORATION disposal group, including discontinued operation, revenue for fiscal 2011 was $141.00M.
- BOSTON SCIENTIFIC CORPORATION disposal group, including discontinued operation, revenue for fiscal 2009 was $11.00M, a 84.06% decline from fiscal 2008.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month | Disposal Group, Including Discontinued Operation, Revenue 12 month as first filed |
|---|---|---|---|---|---|
| 2014-06-30 | $1.00M 10-Q · filed 2014-08-06 | $3.00M 10-Q · filed 2014-08-06 | $5.00M derived: sum of 3 quarters · filed 2014-08-06 | $7.00M derived: sum of 4 quarters · filed 2014-08-06 | |
| 2014-03-31 | $2.00M 10-Q · filed 2014-05-08 | $4.00M derived: sum of 2 quarters · filed 2014-05-08 | $6.00M derived: sum of 3 quarters · filed 2014-05-08 | $25.00M derived: sum of 4 quarters · filed 2014-08-06 | |
| 2013-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $4.00M derived: sum of 2 quarters · filed 2014-02-26 | $23.00M derived: sum of 3 quarters · filed 2014-08-06 | $58.00M 10-K · filed 2014-02-26 | |
| 2013-09-30 | $2.00M 10-Q · filed 2013-11-05 | $21.00M derived: sum of 2 quarters · filed 2014-08-06 | $56.00M 10-Q · filed 2014-11-05 | $88.00M derived: sum of 4 quarters · filed 2014-08-06 | |
| 2013-06-30 | $19.00M 10-Q · filed 2014-08-06 | $55.00M 10-Q · filed 2014-08-06 | $86.00M derived: sum of 3 quarters · filed 2014-08-06 | $118.00M derived: sum of 4 quarters · filed 2014-08-06 | |
| 2013-03-31 | $36.00M 10-Q · filed 2014-05-08 | $67.00M derived: sum of 2 quarters · filed 2014-05-08 | $99.00M derived: sum of 3 quarters · filed 2014-05-08 | $129.00M derived: sum of 4 quarters · filed 2014-05-08 | |
| 2012-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $63.00M derived: sum of 2 quarters · filed 2014-02-26 | $93.00M derived: sum of 3 quarters · filed 2014-02-26 | $122.00M 10-K · filed 2014-02-26 | |
| 2012-09-30 | $32.00M 10-Q · filed 2013-11-05 | $62.00M derived: sum of 2 quarters · filed 2013-11-05 | $91.00M 10-Q · filed 2013-11-05 | $121.00M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-06-30 | $30.00M 10-Q · filed 2013-08-07 | $59.00M 10-Q · filed 2013-08-07 | $89.00M derived: sum of 3 quarters · filed 2014-02-26 | $123.00M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2012-03-31 | $29.00M 10-Q · filed 2013-05-07 | $59.00M derived: sum of 2 quarters · filed 2014-02-26 | $93.00M derived: sum of 3 quarters · filed 2014-02-26 | $136.00M derived: sum of 4 quarters · filed 2014-02-26 | |
| 2011-12-31 | $30.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $64.00M derived: sum of 2 quarters · filed 2014-02-26 | $107.00M derived: sum of 3 quarters · filed 2014-02-26 | $141.00M 10-K · filed 2014-02-26 | |
| 2011-09-30 | $34.00M 10-Q · filed 2012-11-06 | $77.00M derived: sum of 2 quarters · filed 2012-11-06 | $111.00M 10-Q · filed 2012-11-06 | ||
| 2011-06-30 | $43.00M 10-Q · filed 2012-08-07 | $77.00M 10-Q · filed 2012-08-07 | |||
| 2011-03-31 | $34.00M 10-Q · filed 2012-05-03 | ||||
| 2010-12-31 | $340.00M 8-K · filed 2013-05-29 | $4.00M 10-K · filed 2011-02-17 | |||
| 2010-03-31 | $89.00M 10-Q · filed 2011-05-05 | ||||
| 2009-12-31 | $11.00M 10-K · filed 2011-02-17 | ||||
| 2008-12-31 | $69.00M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |